True Wealth Design’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.9K Buy
1,186
+364
+44% +$15.6K 0.01% 442
2026
Q1
$30.2K Buy
822
+464
+130% +$22K 0.01% 556
2025
Q4
$18.2K Sell
358
-85
-19% -$4.35K 0.01% 644
2025
Q3
$24.6K Buy
443
+300
+210% +$17.6K 0.01% 535
2025
Q2
$9.87K Buy
143
+48
+51% +$3.27K ﹤0.01% 587
2025
Q1
$6.59K Sell
95
-55
-37% -$4.54K ﹤0.01% 601
2024
Q4
$12.9K Buy
150
+2
+1% +$216 0.01% 386
2024
Q3
$17.6K Sell
148
-203
-58% -$27.1K 0.01% 341
2024
Q2
$50.1K Buy
351
+235
+203% +$31.1K 0.01% 163
2024
Q1
$14.9K Buy
116
+46
+66% +$5.48K ﹤0.01% 230
2023
Q4
$7.24K Hold
70
﹤0.01% 245
2023
Q3
$6.37K Sell
70
-6
-8% -$529 ﹤0.01% 220
2023
Q2
$6.15K Hold
76
﹤0.01% 237
2023
Q1
$6.05K Hold
76
﹤0.01% 270
2022
Q4
$5.14K Buy
+76
New +$4.46K ﹤0.01% 249

Other funds holding NVO

True Wealth Design's NVO Position: Q2 2026 in Review

True Wealth Design increased its Novo Nordisk (NVO) stake by 44% in Q2 2026, buying an estimated $15.6K and bringing the position to 1,186 shares worth $56.9K. The position accounts for 0.01% of the portfolio, ranked #442.

True Wealth Design first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • True Wealth Design held 1,186 shares of Novo Nordisk worth $56.9K as of Q2 2026.
  • True Wealth Design bought 364 Novo Nordisk shares in Q2 2026, an estimated $15.6K.
  • Novo Nordisk made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #442 holding.
  • True Wealth Design first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.